• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Amedisys

NASDAQ:AMED

$10.93 $0.41 (3.90%)

REAL-TIME: Last trade at

Avondale Upgrades Amedisys (AMED) to Market Perform

Amedisys upgraded earlier to Market Perform from Underperform at Avondale

Correction: Amedisys upgraded to Neutral from Underperform at RW Baird

Amedisys falls 19.2%

Lower Margins Mar Amedisys' 1Q - Analyst Blog

Lower Margins Mar Amedisys' 1Q

Amedisys reaffirms FY12 guidance for EPS 95c-$1.10, revenue $1.475B-$1.525B

Amedisys reports Q1 continuing ops EPS 22c, consensus 22c

Amedisys, Inc. (AMED) Reports In-Line Q1 EPS of 22c; Reaffirms FY12 Guidance

Amedisys helps with swallowing disorders

RN Opportunities - Amedisys, Baton Rouge, LA

Amedisys Receives Highest Recognition from the NHPCO We Honor Veterans Program

CRT Capital Upgrades Amedisys (AMED) to Fairly Valued

Amedisys upgraded to Fair Value from Sell at CRT Capital

Piper Jaffray's medtech research team holds a conference call

Amedisys Announces First Quarter Earnings Release and Conference Call Date

Amedisys Announces First Quarter Earnings Release and Conference Call Date

Spotlight: Leaders in home care

Am I Diversified?

How to spot swallowing problems that put seniors’ lives at risk

Jefferies Raises PT On Amedisys (AMED) To $16.50, Maintains 'Hold'

Jefferies Maintains a 'Hold' on Amedisys (AMED); Raises Numbers To Reflect Benefit Of Agency Rationalization Efforts

Amedisys Scores 19% Above National Average on Treatment Goals Met at Home

Amedisys to Present at the Raymond James 33rd Annual Institutional Investors Conference

Disappointing 4Q for Amedisys - Analyst Blog

Disappointing 4Q for Amedisys

Amedisys 4Q profit drops sharply

Amedisys moves higher after results, resistance is at $14.40

Amedisys, Inc. (AMED) Misses Q4 EPS by 4c; Guides FY12

Amedisys reports Q4 continuing ops EPS 25c, consensus 29c

Amedisys sees FY12 EPS 95c-$1.10, consensus 94c

Amedisys Reports Fourth Quarter Financial Results; Issues 2012 Guidance

Amedisys Increases Access for Managed Care Patients in the Southeast

Amedisys signs managed care agreement with Blue Cross and Blue Shield of GA

Amedisys Signs Managed Care Agreement with Blue Cross and Blue Shield of Georgia

Amedisys® Issues Heart Health Month Call-to-Action

A Battered Healthcare Play With Favorable Long-Term Demographics

Piper Jaffray's medtech research team holds a conference call

Baird Downgrades Amedisys (AMED) to Underperform

Julie Lewis, Vice President of Health Policy for Amedisys Selected by Centers for Medicare and Medicaid Services for New Innovation Advisors Program to Improve Care for Patients

See More Articles...